z-logo
open-access-imgOpen Access
Divalent cations are dispensable for binding to DNA of a novel positively charged olivomycin A derivative
Author(s) -
А. Д. Бениаминов,
Lyubov G. Dezhenkova,
О. К. Мамаева,
Anna K. Shchyolkina,
An. Tevyashova,
Dmitry N. Kaluzhny,
Alexander А. Shtil
Publication year - 2018
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0191923
Subject(s) - divalent , dna , chemistry , stereochemistry , circular dichroism , biophysics , binding site , ionic strength , crystallography , duplex (building) , base pair , biochemistry , biology , organic chemistry , aqueous solution
The current model of binding of the antitumor antibiotic olivomycin A ( 1 ) to GC-rich DNA regions presumes that coordination of the magnesium divalent cation with drug dimers is necessary for binding of 1 into the minor groove of the DNA duplex. Previously we have synthesized the derivatives of 1 termed ‘short acid’ ( 2 ) and its N , N -dimethylaminoethylamide ( 3 ). The latter compound demonstrated an improved tolerance in vivo compared to 1 and good therapeutic potency in animal models. We herein report that compound 3 is able to form stable complexes with DNA in the absence of Mg 2+ , in striking contrast to 1 whose binding to the DNA absolutely requires Mg 2+ . The mode of binding of 3 to DNA is similar in the presence or absence of Mg 2+ as determined by circular dichroism. The affinity to DNA of 3 in Mg 2+ -free solution was similar to that of 1 or 3 in the presence of Mg 2+ at low ionic strength. Non-electrostatic contributions to total free energy of binding of 1 and 3 to DNA were comparable for Mg 2+ -free complexes. Our data strongly suggest that electrostatic interaction of the positively charged 3 can compensate for the absence of divalent ions in complexes with DNA. This new property of the olivomycin A derivative expands the mechanistic knowledge of the modes of interaction with DNA of small molecular weight drug candidates.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here